Skip to main content
Clinical Trials/NL-OMON45689
NL-OMON45689
Completed
Not Applicable

Secondary Manifestations of Arterial Disease - Influence of Cardiovascular Prognosis and Treatment Effect Predictions on Patient and Physician Decision-Making: a Three-armed, Blinded, Randomized Controlled Trial - SMART-INFORM

niversitair Medisch Centrum Utrecht0 sites303 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Clinically manifest atherosclerotic disease
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
303
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 7, 2019
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • 1\. Inclusion in the SMART study (NL45885\.041\.13\)
  • 2\. Clinically manifest cardiovascular disease, such as a confirmed diagnosis or strong clinical suspicion of one of the following: coronary artery disease, cerebrovascular disease, peripheral artery disease.
  • 3\. Use of statin medication at baseline
  • 4\. 45\-80 years of age
  • 5\. Rankin Scale \<3

Exclusion Criteria

  • 1\. Pregnancy
  • 2\. Terminal malignancy or short life\-expectancy
  • 3\. No follow\-up possible
  • 4\. Inability to effectively communicate in Dutch
  • 5\. No informed consent (IC) signed
  • 6\. Baseline questionnaire not returned

Outcomes

Primary Outcomes

Not specified

Similar Trials